Contract research organization (DNA synthesis and biopharma)
Appears in 2 stories
Synthesized designs and tested binding in mammalian cells
Anthropic's Claude model designed small proteins that bind to scorpion neurotoxins, the molecules behind thousands of deaths each year from Mexico to North Africa. Two contract labs tested 211 designs; 17 bound to four of five target toxins, including two with single-digit nanomolar affinity.
Updated 1 hour ago
Providing synthesis and expression capacity for AI-designed antibodies
Artificial intelligence can design tens of thousands of antibody candidates in days. Turning those digital sequences into physical molecules for testing still takes months. PROTEINA and Twist Bioscience announced a partnership on August 27, 2026, to collapse that gap.
Updated Aug 27
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
